KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eqt (EQT) Research & Development (2016 - 2026)

Eqt has reported Research & Development over the past 18 years, most recently at $430000.0 for Q1 2026.

  • Quarterly Research & Development fell 59.09% to $430000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Mar 2026, up 3.83% year-over-year, with the annual reading at $3.6 million for FY2025, 31.66% up from the prior year.
  • Research & Development was $430000.0 for Q1 2026 at Eqt, down from $946000.0 in the prior quarter.
  • Over five years, Research & Development peaked at $1.7 million in Q2 2022 and troughed at $159000.0 in Q4 2024.
  • The 5-year median for Research & Development is $772000.0 (2022), against an average of $796117.6.
  • Biggest five-year swings in Research & Development: crashed 98.26% in 2022 and later soared 494.97% in 2025.
  • Tracing EQT's Research & Development over 5 years: stood at $568000.0 in 2022, then rose by 28.17% to $728000.0 in 2023, then tumbled by 78.16% to $159000.0 in 2024, then soared by 494.97% to $946000.0 in 2025, then crashed by 54.55% to $430000.0 in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $430000.0, $946000.0, and $331000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.